A 2026 CDC-funded study found GBS diagnoses about 2.5 times the expected rate after Tdap, adding new evidence for vaccine injury claims in the VICP.
Our Latest Insights
From vaccine injury and product liability to complex federal claims, we break down the legal issues, real cases, and evolving questions that shape our work. Whether you are trying to understand your options or follow how these cases unfold, this is where it starts to make sense.
A 2026 CDC-funded study found GBS diagnoses about 2.5 times the expected rate after Tdap, adding new evidence for vaccine injury claims in the VICP.
Free Consultation